Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-TNF mode of action?

A. Finckh; D. Courvoisier; J.-E. Gottenberg; X. Mariette; J. Morel; S. A. Bergstra; V. Hernandez; C. Codreanu; T. K.  Kvien; M. J. Santos; K. Pavelka; Merete Lund Hetland; K. Chatzidionysiou; J. Askling; C. Turesson; C. Gabay; R. Van Vollenhoven

Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-TNF mode of action?

A. Finckh, D. Courvoisier, J.-E. Gottenberg, X. Mariette, J. Morel, S. A. Bergstra, V. Hernandez, C. Codreanu, T. K. Kvien, M. J. Santos, K. Pavelka, Merete Lund Hetland, K. Chatzidionysiou, J. Askling, C. Turesson, C. Gabay, R. Van Vollenhoven

Department for Rheumatology and Spine Diseases

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	76
Issue number	Suppl 2
Pages (from-to)	567
Number of pages	1
ISSN	0003-4967
Publication status	Published - 2017

Cite this

Finckh, A., Courvoisier, D., Gottenberg, J.-E., Mariette, X., Morel, J., Bergstra, S. A., Hernandez, V., Codreanu, C., Kvien, T. K., Santos, M. J., Pavelka, K., Hetland, M. L., Chatzidionysiou, K., Askling, J., Turesson, C., Gabay, C., & Van Vollenhoven, R. (2017). Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-TNF mode of action? Annals of the Rheumatic Diseases, 76(Suppl 2), 567.

Finckh, A, Courvoisier, D, Gottenberg, J-E, Mariette, X, Morel, J, Bergstra, SA, Hernandez, V, Codreanu, C, Kvien, TK, Santos, MJ, Pavelka, K, Hetland, ML, Chatzidionysiou, K, Askling, J, Turesson, C, Gabay, C & Van Vollenhoven, R 2017, 'Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-TNF mode of action?', Annals of the Rheumatic Diseases, vol. 76, no. Suppl 2, pp. 567.

@article{7ed0d39c98724e528f1fc23fd8a96476,

title = "Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-TNF mode of action?",

author = "A. Finckh and D. Courvoisier and J.-E. Gottenberg and X. Mariette and J. Morel and Bergstra, {S. A.} and V. Hernandez and C. Codreanu and Kvien, {T. K.} and Santos, {M. J.} and K. Pavelka and Hetland, {Merete Lund} and K. Chatzidionysiou and J. Askling and C. Turesson and C. Gabay and {Van Vollenhoven}, R.",

note = "COPECARE",

year = "2017",

language = "English",

volume = "76",

pages = "567",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",